"Date|Symbol|ShortVolume|ShortExemptVolume|TotalVolume

New Post Public Reply Private Reply Replies (2) Message Board
F1ash AlanC #35529
411
"Date|Symbol|ShortVolume|ShortExemptVolume|TotalVolume Market



20170703|INTK|56666|0|161000|O
20170703|INVT|19999|0|58801|O
20170703|INVVY|100|0|593|O
20170703|IOBCF|100|0|100|O
20170703|IPIX|45262|0|150103|O
20170703|IPPLF|210|0|951|O
20170703|IPXHY|3436|0|13016|O
20170703|ISBG|2359473|0|52841199|O
20170703|ISCO|57|0|4077|O
20170703|ISDAY|289|0|950|O
20170703|ISHOF|2|0|2|O
20170703|ISMAY|9049|0|15987|O
20170703|ISNPY|29807|0|123925|O
20170703|ISRHF|177|0|177|O
20170703|ISRPF|827|0|827|O
20170703|ISRUF|52|0|52|O
20170703|ISRZF|20|0|20|O
20170703|ISUPF|3|0|867|O
20170703|ISUZY|265|0|2671|O
20170703|ISVLF|15500|0|226400|O
20170703|ISXIF|320|0|320|O
20170703|ISXPF|1266|0|1266|O
20170703|ITHUF|10850|0|16475|O
20170703|ITKG|484367|0|1577958|O
20170703|ITOCY|2205|0|2415|O
20170703|ITPOF|56|0|518|O
20170703|ITVPY|292|0|1763|O
20170703|IVFH|976|0|11976|O
20170703|IVITF|16761|0|24561|O
20170703|IVPAF|18758|0|25571"

Here are the numbers for just a small sampling of other companies on the same exchange.

http://regsho.finra.org/FORFshvol20170703.txt

Now everyone can look daily for themselves. Seems obvious, when viewed in relation to others, there is nothing nefarious occurring with this company in relations to "naked shorting". Iit's just a misunderstood stat. It is in line with the norm for all companies on this exchange.

Here's some more:


20170703|JSTTY|3219|0|3704|O
20170703|JTCMF|4999|0|5699|O
20170703|JUMSY|74|0|74|O
20170703|JXHLY|748|0|748|O
20170703|KAJMY|83|0|83|O
20170703|KALO|10000000|0|10000000|O
20170703|KALTF|6999|0|16798|O
20170703|KALY|1094413|0|6797984|O
20170703|KATFF|20534|0|93349|O
20170703|KATYQ|20000|0|20000|O

Goodness gracious KALO looks like it had 100% naked short volume. The shorts are in trouble over there for sure. Bet they could use your help over on that board.

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials